Connor, Clark & Lunn Investment Management (CC&L)’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.1M Buy
777,734
+27,716
+4% +$482K 0.04% 345
2025
Q4
$8.84M Buy
750,018
+483,602
+182% +$6.21M 0.02% 489
2025
Q3
$4.22M Buy
266,416
+223,209
+517% +$3.24M 0.01% 631
2025
Q2
$495K Buy
+43,207
New +$487K ﹤0.01% 1259
2023
Q2
Sell
-11,006
Closed -$330K 1332
2023
Q1
$330K Buy
+11,006
New +$363K ﹤0.01% 992
2021
Q2
Sell
-180,872
Closed -$5.05M 983
2021
Q1
$5.05M Sell
180,872
-286,404
-61% -$7.62M 0.03% 352
2020
Q4
$11.6M Sell
467,276
-25,537
-5% -$608K 0.07% 210
2020
Q3
$10.3M Buy
492,813
+129,293
+36% +$2.49M 0.07% 195
2020
Q2
$5.58M Sell
363,520
-348,173
-49% -$4.4M 0.04% 276
2020
Q1
$6.31M Sell
711,693
-266,871
-27% -$3.85M 0.06% 222
2019
Q4
$17.7M Sell
978,564
-384,979
-28% -$6.39M 0.12% 133
2019
Q3
$20.4M Buy
1,363,543
+571,293
+72% +$9.29M 0.14% 120
2019
Q2
$19M Buy
792,250
+781,475
+7,253% +$23M 0.12% 127
2019
Q1
$400K Sell
10,775
-20,825
-66% -$758K ﹤0.01% 702
2018
Q4
$892K Buy
+31,600
New +$1,000K 0.01% 572
2016
Q2
Sell
-198,355
Closed -$1.39M 871
2016
Q1
$1.39M Buy
198,355
+4,620
+2% +$23.2K 0.01% 400
2015
Q4
$1.04M Buy
193,735
+131,875
+213% +$843K 0.01% 444
2015
Q3
$400K Buy
+61,860
New +$648K ﹤0.01% 559

Other funds holding CC

Connor, Clark & Lunn Investment Management (CC&L)'s CC Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) increased its Chemours (CC) stake by 3.7% in Q1 2026, buying an estimated $482K and bringing the position to 777,734 shares worth $17.1M. The position accounts for 0.04% of the portfolio, ranked #345.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CC in Q3 2015 and has held it in 18 quarters since. The position peaked at $20.4M in Q3 2019. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 777,734 shares of Chemours worth $17.1M as of Q1 2026.
  • Connor, Clark & Lunn Investment Management (CC&L) bought 27,716 Chemours shares in Q1 2026, an estimated $482K.
  • Chemours made up 0.04% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q1 2026, its #345 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Chemours in Q3 2015 and has held it in 18 quarters since.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Chemours position peaked at $20.4M in Q3 2019.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.